SANA — Sana Biotechnology Share News
0.000.00%
Last trade - 00:00- $709.48m
- $548.99m
Brief: Sana Biotechnology Q1 Adjusted EPS USD -0.32 Vs. IBES Estimate USD -0.32
Sana Biotechnology Inc expected to post a loss of 32 cents a share - Earnings Preview
Brief: Sana Biotechnology Q4 Adjusted EPS USD -0.35 Vs. IBES Estimate USD -0.38
U.S. STOCKS ON THE MOVE-S&P Global, Hershey, Under Armour
U.S. STOCKS ON THE MOVE-ConocoPhillips, Advanced Drainage Systems, Molina Healthcare
Sana Biotechnology rises after upsized stock offering prices
Brief: Sana Biotechnology Announces Pricing Of Upsized Public Offering
Brief: Sana Biotechnology Inc Estimates Its Cash, Cash Equivalents And Marketable Securities As Of Jan 2, 2024 Were About $205.4 Million
Sana Biotechnology tumbles on stock offering launch
Brief: Sana Biotechnology Announces Proposed Public Offering Of Common Stock
Sana Biotech rises on FDA clearance to initiate cancer therapy trial
U.S. RESEARCH ROUNDUP- Compass Minerals International, Equinix, Kingstone Companies
Brief: Uppsala University Hospital And Sana Biotechnology Announce Authorization
Sana Biotechnology Inc expected to post a loss of 45 cents a share - Earnings Preview
Sana Biotech to cut jobs, shares gain
Brief: Sana Biotechnology Announces Increased Focus On Hypoimmune-Related Pipeline
Brief: Sana Biotechnology On Sept 12, Spokesperson Said Expects To File An Ind Filing For Sc291 Product Candidate In Autoimmune Diseases In Q4 2023
Sana Biotechnology Inc reports results for the quarter ended in June - Earnings Summary
Brief: Sana Biotechnology Q2 Adjusted EPS USD -0.45